Mantle cell lymphoma causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
* The typical mutation occurring in mantle cell lymphoma causes the over expression of cyclin D1 which results in uncontrolled growth of B cells leading to lymphoma development. | * The typical mutation occurring in mantle cell lymphoma causes the over expression of cyclin D1 which results in uncontrolled growth of B cells leading to lymphoma development. | ||
* Recently, weak associations have been observed in the development of mantle cell lymphoma with the following: | * Recently, weak associations have been observed in the development of mantle cell lymphoma with the following: | ||
# With exposure to European strains of Borellia burgdoferi. | # With exposure to European strains of Borellia burgdoferi.<ref name="pmid18424667">{{cite journal| author=Schöllkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B et al.| title=Borrelia infection and risk of non-Hodgkin lymphoma. | journal=Blood | year= 2008 | volume= 111 | issue= 12 | pages= 5524-9 | pmid=18424667 | doi=10.1182/blood-2007-08-109611 | pmc=2972577 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18424667 }} </ref> | ||
# Family history of hematologic malignancy. | # Family history of hematologic malignancy.<ref name="pmid17185468">{{cite journal| author=Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L et al.| title=Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). | journal=Blood | year= 2007 | volume= 109 | issue= 8 | pages= 3479-88 | pmid=17185468 | doi=10.1182/blood-2006-06-031948 | pmc=1852242 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17185468 }} </ref> | ||
# Genetic polymorphisms in the pro-inflammatory cytokine IL-10. | # Genetic polymorphisms in the pro-inflammatory cytokine IL-10.<ref name="pmid20047977">{{cite journal| author=Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM et al.| title=Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. | journal=Am J Epidemiol | year= 2010 | volume= 171 | issue= 3 | pages= 267-76 | pmid=20047977 | doi=10.1093/aje/kwp383 | pmc=2842204 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20047977 }} </ref> | ||
However, factors that initiate the genetic alterations are typically not identifiable, and usually occur in people with no particular risk factors for lymphoma development. | However, factors that initiate the genetic alterations are typically not identifiable, and usually occur in people with no particular risk factors for lymphoma development. | ||
Revision as of 17:25, 8 November 2018
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma causes On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma causes |
Risk calculators and risk factors for Mantle cell lymphoma causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
The causes of mantle cell lymphoma have not been clearly identified.
Causes
- Mantle cell lymphoma, like most malignancies, results from the acquisition of a combination of (non-inherited) genetic mutations in somatic cells.
- The typical mutation occurring in mantle cell lymphoma causes the over expression of cyclin D1 which results in uncontrolled growth of B cells leading to lymphoma development.
- Recently, weak associations have been observed in the development of mantle cell lymphoma with the following:
- With exposure to European strains of Borellia burgdoferi.[1]
- Family history of hematologic malignancy.[2]
- Genetic polymorphisms in the pro-inflammatory cytokine IL-10.[3]
However, factors that initiate the genetic alterations are typically not identifiable, and usually occur in people with no particular risk factors for lymphoma development.
References
- ↑ Schöllkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B; et al. (2008). "Borrelia infection and risk of non-Hodgkin lymphoma". Blood. 111 (12): 5524–9. doi:10.1182/blood-2007-08-109611. PMC 2972577. PMID 18424667.
- ↑ Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L; et al. (2007). "Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)". Blood. 109 (8): 3479–88. doi:10.1182/blood-2006-06-031948. PMC 1852242. PMID 17185468.
- ↑ Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM; et al. (2010). "Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium". Am J Epidemiol. 171 (3): 267–76. doi:10.1093/aje/kwp383. PMC 2842204. PMID 20047977.